Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 18/20 | 0.63 |
| ▸ | HTR1A | P08908 | 9/20 | 0.63 |
| ▸ | DRD2 | P14416 | 4/20 | 0.59 |
| ▸ | DRD5 | P21918 | 4/20 | 0.59 |
| ▸ | DRD3 | P35462 | 4/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5999408 | 0.87 | HTR7 (0.57) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL19691138 | 0.86 | HTR7 (0.62) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL30363927 | 0.86 | HTR7 (0.62) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL23339326 | 0.84 | HTR7 (0.63) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL9049355 | 0.84 | HTR7 (0.63) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL15396975 | 0.84 | HTR7 (0.63) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL2491730 | 0.83 | HTR7 (0.62) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL7476444 | 0.81 | DRD2 (0.63) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL318584 | 0.81 | HTR7 (0.59) | HTR7HTR1ADRD2DRD5DRD3 | |
| SCHEMBL3805479 | 0.81 | HTR7 (0.72) | HTR7HTR1ADRD2DRD5DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270763-A1 | METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES | PASCAL BIOSCIENCES INC (CA) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270763-A1 | METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES | CNR1, CNR2, SARS1 | HTR7 129/4885HTR1A 25/4885DRD2 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.